Overview
AdductNE is a radiopharmaceutical company spun-out from the University of Nebraska Medical Center (UNMC) in 2019. AdductNE is dedicated to developing targeted imaging and therapeutic agents for cancer.
Leadership
-
Jered Christopher Garrison, PhD
President & Chief Scientific Officer
-
Shana Garrison, PhD
Chief Financial Officer